137862-53-4 |
3-Methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-butanoic acid |
N-(1-OXOPENTYL)-N-[[2'-(1H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-L-VALINE;VALSARTAN;CGP-48933;DIOVAN;3-methyl-2-[pentanoyl-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-butanoic acid;VALSARTAN, MM STANDARD;VALSARTAN, USP STANDARD;VALSARTAN, RELATED COMPOUND A(R)-N-VALERYL-N-([2'-(1-H-TETRAZOLE)-5-YL)-BIPHENYL-4-YL]-METHYL)-VALINE USP STANDARD |
C24H29N5O3 |
40
supplier(s) 137862-53-4 |
107868-30-4 |
Exemestane |
Exemestan; 6-Methylenandrosta-1,4-diene-3,17-dione; 10,13-Dimethyl-6-methylidene-7,8,9,10,11,12,13,14,15,16-decahydrocyclopenta[a]phenanthrene-; 6-methylideneandrosta-1,4-diene-3,17-dione; (8ξ,9ξ,14ξ)-6-methylideneandrosta-1,4-diene-3,17-dione |
C20H24O2 |
17
supplier(s) 107868-30-4 |
100986-85-4 |
Levofloxacin hydrochloride |
(s)-ofloxacin;7h-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylicacid,2,3-dihydro-9-fluoro-3-m;dr3355;hemihydrate,(s)-ethyl-10-(4-methyl-1-piperazinyl)-7-oxo;LEVOFLOXACIN HCL;LEVOFLOXACIN HEMIHYDRATE;(3s)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid monohydrochloride;Levofloxacin base |
C18H20FN3O4 |
24
supplier(s) 100986-85-4 |
119478-56-7 |
Meropenem trihydrate |
(4R,5S,6S)-3-[[(3S,5S)-5-(Dimethylcarbamoyl)-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid trihydrate; Meropenem (with carbonate); (4R,5S,6S)-3-{[(2S,5S)-5-(dimethylcarbamoyl)pyrrolidin-2-yl]sulfanyl}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; (4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid trihydrate; (4S,5R,6R)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid |
C17H25N3O5S |
13
supplier(s) 119478-56-7 |
134523-03-8 |
Atorvastatin Calcium |
ATORVASTATIN CA; [r-(r*, r*)]-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylaminocarbonyl)-1h-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid calcium salt; 1h-pyrrole-1-heptanoicacid,beta,delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methy calciumsalt(2:1),(r-(r*,r*))-lethyl)-3-phenyl-4-((phenylamino)carbonyl); delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-betcalci1h-pyrrole-1-heptanoicaci; pd134298-38a; ATORVASTATINCALCUIM; calcium (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-p ropan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoate; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5 -(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-calcium salt (2: 1), (R-(R*,R*))-; 1H-Pyrrole-1-heptanoic acid; beta,delta-dihydroxy-2-(4-fluorophenyl)-5 -(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-calcium salt (2: 1); (R-(R*,R*))-, Atorvastatin calcium; Atorvastatin calcium (USAN); Atorvastatin calcium salt; Atorvastatin calcium [USAN]; C08078; Calcium (betaR,deltaR)-2-(p-fluorophenyl)-beta,delta-dihydroxy-5-isopr opyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoate (1:2); CI-981; D00887; DRG-0321; Lipibec; Lipitor; Lipitor (TN); LS-136974; PD 134298-38A; Prevencor; Sortis; Tahor; Torvast; YM-548; Atorvastatin Calsium; (3R,5R)-7-[2-(4-Fluorophenyl)-5-Isopropyl-3-Phenyl-4-(Pheynylcarbamoyl)Pyrrol-1-yl]-3,5-Dihydroheptanoic Acid,calcium salt; (3R,5R)-7-[2-(4-Fluorophenyl)-5-Isopropyl-3-Phenyl-4-(Pheynylcarbamoyl)Pyrrol-1-yl]-3,5_Dihydroheptanoic Acid,calcium salt |
C66H68Ca2F2N4O10 |
28
supplier(s) 134523-03-8 |
134678-17-4 |
Lamivudine |
(-)-BCH-189;(-)-BETA-L-2',3'-DIDEOXY-3'-THIACYTIDINE;(-)-B-L-2',3'-DIDEOXY-3'-THIACYTIDINE;(2r-cis)-4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1h)-pyrimidinone;2'-deoxy-3'-thiacytidine;4-AMINO-1-((2R,5S)-2-HYDROXYMETHYL-[1,3]OXATHIOLAN-5-YL)-1H-PYRIMIDIN-2-ONE;3TC;3'-THIA-2',3'-DIDEOXYCYTIDINE |
C8H11N3O3S |
19
supplier(s) 134678-17-4 |
151-73-5 |
betamethasone 21-phosphate sodium |
betamethasone 21-(disodium phosphate); BETA METHASONE SODIUM PHOSPHATE; 20-dione,9-fluoro-11-beta,17,21-trihydroxy-16-beta-methyl-pregna-4-diene-3; 21-(dihydrogenphosphate),disodiumsalt; bentelan; betamethasonedisodiumphosphate; BETMETHASONE DISODIUM PHOSPHATE; betnesol; BETAMETHASONE 21-DISODIUM PHOSPHATE; betamethasone 21-phosphate disodium; BETAMETHASONE 21-PHOSPHATE SODIUM SALT; BETAMETHASONE SODIUM PHOSPHATE; 9a-fluoro-16b-methylprednisolone-21-(disodium phosphate); 1,4-PREGNADIEN-9-ALPHA-FLUORO-16-BETA-METHYL-11-BETA, 17,21-TRIOL-3,20-DIONE 21-PHOSPHATE, DISODIUM SALT; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, disodium salt, (11beta,16beta)-; Pregna-1,4-Diene-3,20-Dione,9-Fluoro-11,17-Dihydroxy-16-Methyl-21-(Phosphonooxy)-,DisodiumSalt,(11Beta,16Beta)-; BETAMETHASONE 21-PHOSPHATE DISODIUM SALT; BETAMETHASONESODIUMPHOSPHATE,USP; Celestan; Disodium betamethasone 21-phosphate; Durabetason; NSC 90616; Pregna-1,4-diene-3,20-dione, 9-fluoro-11β,17,21-trihydroxy-16β-methyl-, 21-(dihydrogen phosphate), disodium salt (7CI, 8CI); Vista-Methasone; disodium (11beta,16beta)-9-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl phosphate |
C22H28FNa2O8P |
8
supplier(s) 151-73-5 |
112811-59-3 |
Gatifloxacin |
1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
C19H22FN3O4 |
17
supplier(s) 112811-59-3 |
101-20-2 |
3,4,4'-trichlorocarbanilide |
TCC; solubacter; Procutene; N-(3,4-DICHLOROPHENYL)-N'-(4-CHLOROPHENYL)UREA; N-(4-CHLOROPHENYL)-N-(3,4-DICHLOROPHENYL)-UREA; TRICHLOROCARBANILIDE; TRICLOCARBAN; 3,4,4’-trichloro-carbanilid; 1-(4-chlorophenyl)-3-(3,4-dichlorophenyl)urea; 1-(3,4-dichlorophenyl)-3-phenylurea; 3,4,4'- Trichloro-sym-diphenylurea; 3,4,4'-trichlorocarbanilide |
C13H9Cl3N2O |
5
supplier(s) 101-20-2 |
131929-60-7 |
spinosad |
spinosyn D; (2R,3aS,5aR,5bS,9S,14R,16aS,16bR)-13-{[(2R,5S,6R)-5-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy}-9-ethyl-14-methyl-7,15-dioxo-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-1H-as-indaceno[3,2-d]oxacyclododecin-2-yl 6-deoxy-2,3,4-tri-O-methyl-alpha-L-mannopyranoside; (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-13-{[(2R,5S,6R)-5-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy}-9-ethyl-14-methyl-7,15-dioxo-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-1H-as-indaceno[3,2-d]oxacyclododecin-2-yl 6-deoxy-2,3,4-tri-O-methyl-alpha-L-mannopyranoside; (5aR,5bS,14R,16bR)-13-{[5-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy}-9-ethyl-14-methyl-7,15-dioxo-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-1H-as-indaceno[3,2-d]oxacyclododecin-2-yl 6-deoxy-2,3,4-tri-O-methylhexopyranoside |
C41H65NO10 |
9
supplier(s) 131929-60-7 |